Hyogo, Japan

Sadao Ohama

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1984.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sadao Ohama: Innovator in Pharmaceutical Technology

Introduction

Sadao Ohama is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and manufacturing processes of medicinal compounds.

Latest Patents

Sadao Ohama holds a patent for a "Suppository containing sulfamethoxazole/trimethoprim complex and process." This invention involves a suppository that contains a one-to-one complex of sulfamethoxazole and trimethoprim, which is dispersed in a pharmaceutically acceptable carrier. The formulation may also include a supplemental amount of sulfamethoxazole, making it superior to conventional preparations. This innovation not only improves the manufacturing process but also enhances the pharmacokinetical properties of the drug.

Career Highlights

Sadao Ohama is associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to focus on creating advanced pharmaceutical solutions that address various health challenges.

Collaborations

Throughout his career, Sadao Ohama has collaborated with esteemed colleagues, including Yasushi Takagishi and Kiichiro Ohsuga. These collaborations have contributed to the advancement of pharmaceutical technologies and the successful development of innovative products.

Conclusion

Sadao Ohama's contributions to pharmaceutical innovation, particularly through his patented work, highlight his role as a key figure in the industry. His dedication to improving drug delivery systems continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…